Arturo Molina, MD | Authors

INEZ DRUG STORE

PO BOX 381

Articles

Clinical Status and Optimal Use of Rituximab for B-Cell Lymphomas

December 01, 1998

The standard management of low-grade lymphoma remains controversial. Long-term follow-up studies of patients treated with conventional regimens have shown that currently available treatments are not curative.